Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

A type of gut bacteria may increase risk of bowel cancer

People with a certain type of bacteria in their guts may be more likely to develop bowel cancer.

4 Nov 2019

Certain gut bacteria can increase the risk of bowel cancer, shows study

People who have a certain type of bacteria in their guts may be at greater risk of developing bowel cancer.

3 Nov 2019

Can Probiotics Support Healthy Kidney Function?

An interview with Dr Natarajan Ranganathan, key founder and Managing Director of Kibow Biotech Inc. about the use of probiotics for supporting healthy kidney function.

From Kibow Biotech Inc. 30 Oct 2019

ACG 2019 to review latest scientific advances in diagnosis and treatment of digestive diseases

More than 5,500 gastroenterologists and other health care professionals will convene at the Henry B. Gonzalez Convention Center in San Antonio, TX for the premier clinical gastroenterology event - the American College of Gastroenterology's 84th Annual Scientific Meeting and Postgraduate Course (ACG 2019) - to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

30 Oct 2019

A healthy diet also helps the environment

We have been advised time and again to eat a healthy and balanced diet. A new study has revealed that eating a healthy diet not only benefits the individual but also the environment. Researchers from the University of Oxford was published in the latest issue of the journal Proceedings of the National Academy of Sciences. The study is titled, “Multiple health and environmental impacts of foods”.

29 Oct 2019

Researchers receive NCI grant to increase colorectal cancer screening in Appalachia

Cancer-control researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of Kentucky aim to increase colorectal cancer screening and follow-up care among underserved individuals in Appalachia through a multi-institutional $5.7 million grant from the National Cancer Institute.

29 Oct 2019

Researchers discover unexpected role of mTORC2 protein in colorectal cancer

New results from researchers at MedUni Vienna's Center for Pathobiochemistry and Genetics show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer. mTORC2 activity was only found in certain immune cells, which actually need this protein to fight cancer cells.

24 Oct 2019

Disrupting key immune regulator boosts anti-tumor immunity, enables cancer clearance

The immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time restraining its activity to avoid inadvertently attacking the body's healthy tissues and organs.

23 Oct 2019

Researchers identify cancer symptom clusters using EHR data

Patients with chronic diseases such as breast cancer or colorectal cancer often experience fatigue, pain, depression and other symptoms which can lead to distress and functional impairment if left untreated.

22 Oct 2019

Newly discovered organelle could help prevent cancer

Scientists at the University of Virginia School of Medicine have discovered a strange new organelle inside our cells that helps to prevent cancer by ensuring that genetic material is sorted correctly as cells divide.

22 Oct 2019

IBD far more common than expected, and will only increase in future

There are three times as many people with the chronic and debilitating bowel disorder called inflammatory bowel disease (IBD) as ever thought before, according to a new study presented today at UEG Week 2019, at Barcelona. Not only is the condition a distressing one in itself, but patients with IBD have a higher risk of colorectal cancer as well.

21 Oct 2019

Researchers identify an immune cell that helps keep time in the gut

As people go through their daily and nightly routines, their digestive tracts follow a routine, too: digesting food and absorbing nutrients during waking hours, and replenishing worn-out cells during sleep. Shift work and jet lag can knock sleep schedules and digestive rhythms out of whack.

4 Oct 2019

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

Innovative drug treatment developed for familial adenomatous polyposis

Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.

3 Oct 2019

Increased intake of dietary fiber lowers risk of hypertension and type 2 diabetes

Dietary fiber has been found to reduce the risk of high blood pressure and type 2 diabetes in a study presented at the American College of Cardiology Middle East Conference 2019.

3 Oct 2019

Innovative compound kills cancer cells, minimizes damage to normal tissues

Most of the current clinical anti-tumor drugs used in chemotherapy move around in the patient's blood after intake and are unable to pinpoint the targeted tumor. As a result, while killing the tumor cells, the healthy cells may also be killed as "collateral damage", leading to undesired side effects.

3 Oct 2019

Certain fungi increase pancreatic cancer risk, study finds

Certain fungi move from the gut to the pancreas, expand their population more than a thousand-fold, and encourage pancreatic cancer growth, a new study finds.

2 Oct 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

A clinical trial has shown that using a combination of three drugs that target a BRAF gene mutation in patients with mCRC effectively boosts overall survival.

30 Sep 2019

Study: Three-drug combination improves overall survival in patients with mCRC

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

30 Sep 2019